IgG antibodies produced during subcutaneous allergen immunotherapy mediate inhibition of basophil activation via a mechanism involving both FcγRIIA and FcγRIIB
Carol Cady(University of Colorado Denver), John C. Cambier(University of Denver), Ronald J. Harbeck(University of Colorado Denver), Syd Johnson(MacroGenics (United States)), Maree S. Powell(Burnet Institute), Patricia C. Giclas(Johns Hopkins University), Rohit Katial(National Jewish Health), Scott Koenig(MacroGenics (United States)), Richard W. Weber(National Jewish Health), P. Mark Hogarth(Burnet Institute), James R. Murphy(University of Liverpool), Ezio Bonvini(MacroGenics (United States))
Cited by 87
Related Papers
Genetic Epidemiology of COPD (COPDGene) Study Design
|COPD Journal of Chronic Obstructive Pulmonary Disease|2010|1.3k
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program
|Journal of Allergy and Clinical Immunology|2007|933
The Clinical Significance of Positive Blood Cultures: A Comprehensive Analysis of 500 Episodes of Bacteremia and Fungemia in Adults. I. Laboratory and Epidemiologic Observations
|Clinical Infectious Diseases|1983|754
Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites
|Nature|1987|503
Variants in FAM13A are associated with chronic obstructive pulmonary disease
|Nature Genetics|2010|423